Pediatric thrombosis: Risk factors, diagnosis, and prevention strategies
- PMID: 40696594
- PMCID: PMC12282729
- DOI: 10.1097/MD.0000000000043370
Pediatric thrombosis: Risk factors, diagnosis, and prevention strategies
Abstract
Pediatric thrombosis is an underdiagnosed condition with potentially life-threatening consequences. Unlike adult thrombosis, the pediatric variant is characterized by age-specific risk factors, such as central venous catheters, infections, and genetic predispositions, which demand a tailored approach to diagnosis and management. Neonates and adolescents are particularly vulnerable due to physiological and hormonal changes, respectively, that amplify their susceptibility to thrombotic events. A deeper understanding of these factors is crucial for early detection and effective prevention strategies. The diagnostic process for pediatric thrombosis is fraught with challenges owing to the nonspecific nature of symptoms and variability in presentation across age groups. Imaging modalities, such as Doppler ultrasound and computed tomography pulmonary angiography, remain the cornerstone for identifying thrombotic events. However, laboratory investigations, including thrombophilia testing and d-dimer assays, are essential adjuncts, particularly in cases of idiopathic or recurrent thrombosis. Timely and accurate diagnosis is pivotal for reducing morbidity and mortality associated with this condition.
Keywords: anticoagulation; diagnosis; pediatric thrombosis; prevention; risk factors.
Copyright © 2025 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The author has no funding and conflicts of interest to disclose.
Similar articles
-
Systemic Inflammatory Response Syndrome.2025 Jun 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jun 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31613449 Free Books & Documents.
-
Stopping anticoagulation for isolated or incidental pulmonary embolism: the STOPAPE RCT protocol.Health Technol Assess. 2024 Jun;29(11):1-17. doi: 10.3310/HRCW7937. Health Technol Assess. 2024. PMID: 38970429 Free PMC article.
-
Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.Cochrane Database Syst Rev. 2018 Jul 13;7(7):CD012534. doi: 10.1002/14651858.CD012534.pub2. Cochrane Database Syst Rev. 2018. PMID: 30004572 Free PMC article.
-
Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.Cochrane Database Syst Rev. 2005 Jul 20;(3):CD002772. doi: 10.1002/14651858.CD002772.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2008 Apr 16;(2):CD002772. doi: 10.1002/14651858.CD002772.pub3. PMID: 16034876 Updated.
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
References
-
- Manlhiot C, Menjak IB, Brandao LR, et al. Risk, clinical features, and outcomes of thrombosis associated with pediatric cardiac surgery. Circulation. 2011;124:1511– 9. - PubMed
-
- Giglia TM, Massicotte MP, Tweddell JS, et al. Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2013;128:2622–703. - PubMed
-
- Spentzouris G, Scriven RJ, Lee TK, Labropoulos N. Pediatric venous thromboembolism in relation to adults. J Vasc Surg. 2012;55:1785–93. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical